Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 7061 | 24.23 |
09:34 ET | 11351 | 24.265 |
09:36 ET | 2700 | 24.295 |
09:38 ET | 2443 | 24.3 |
09:39 ET | 3468 | 24.26 |
09:41 ET | 14473 | 24.295 |
09:43 ET | 3480 | 24.255 |
09:45 ET | 200 | 24.22 |
09:48 ET | 64759 | 24.09 |
09:50 ET | 10191 | 24.0201 |
09:52 ET | 2001 | 24.07 |
09:54 ET | 800 | 24.075 |
09:56 ET | 2800 | 24.03 |
09:57 ET | 3500 | 24.03 |
09:59 ET | 1000 | 24.02 |
10:01 ET | 4472 | 24.01 |
10:03 ET | 1086475 | 24.06 |
10:06 ET | 7865 | 24.195 |
10:08 ET | 6480 | 24.34 |
10:10 ET | 3327 | 24.35 |
10:12 ET | 4929 | 24.345 |
10:14 ET | 13730 | 24.83 |
10:15 ET | 25007 | 24.77 |
10:17 ET | 6538 | 24.65 |
10:19 ET | 3009 | 24.705 |
10:21 ET | 16003 | 24.705 |
10:24 ET | 10173 | 24.675 |
10:26 ET | 5506 | 24.71 |
10:28 ET | 5118 | 24.62 |
10:30 ET | 4454 | 24.51 |
10:32 ET | 2810 | 24.465 |
10:33 ET | 6256 | 24.5 |
10:35 ET | 3812 | 24.535 |
10:37 ET | 3630 | 24.39 |
10:39 ET | 4700 | 24.42 |
10:42 ET | 2300 | 24.45 |
10:44 ET | 2200 | 24.39 |
10:46 ET | 2440 | 24.33 |
10:48 ET | 2338 | 24.325 |
10:50 ET | 10841 | 24.31 |
10:51 ET | 1055 | 24.25 |
10:53 ET | 1300 | 24.18 |
10:55 ET | 3132 | 24.2 |
10:57 ET | 1999 | 24.25 |
11:00 ET | 5287 | 24.225 |
11:02 ET | 18743 | 24.24 |
11:04 ET | 910 | 24.195 |
11:06 ET | 800 | 24.15 |
11:08 ET | 2097 | 24.155 |
11:09 ET | 2467 | 24.14 |
11:11 ET | 2400 | 24.155 |
11:13 ET | 3292 | 24.13 |
11:15 ET | 2300 | 24.09 |
11:18 ET | 1932 | 24.07 |
11:20 ET | 2499 | 24.105 |
11:22 ET | 1273 | 24.07 |
11:24 ET | 2300 | 24.05 |
11:26 ET | 7065 | 24.035 |
11:27 ET | 2000 | 24.04 |
11:29 ET | 100 | 24.06 |
11:31 ET | 1600 | 24.065 |
11:33 ET | 1100 | 24.09 |
11:36 ET | 1000 | 24.13 |
11:38 ET | 946 | 24.1542 |
11:40 ET | 800 | 24.17 |
11:42 ET | 1000 | 24.18 |
11:44 ET | 1000 | 24.17 |
11:45 ET | 2626 | 24.2 |
11:47 ET | 2100 | 24.235 |
11:49 ET | 1647 | 24.28 |
11:51 ET | 2230 | 24.28 |
11:54 ET | 600 | 24.3 |
11:56 ET | 4238 | 24.315 |
11:58 ET | 4095 | 24.29 |
12:00 ET | 1777 | 24.315 |
12:02 ET | 1624 | 24.305 |
12:03 ET | 12212 | 24.36 |
12:05 ET | 200 | 24.375 |
12:07 ET | 2700 | 24.335 |
12:09 ET | 1300 | 24.35 |
12:12 ET | 1039 | 24.42 |
12:14 ET | 1737 | 24.47 |
12:16 ET | 1763 | 24.47 |
12:18 ET | 200 | 24.47 |
12:20 ET | 900 | 24.49 |
12:21 ET | 3381 | 24.525 |
12:23 ET | 1320 | 24.53 |
12:25 ET | 2423 | 24.505 |
12:27 ET | 4619 | 24.405 |
12:30 ET | 300 | 24.36 |
12:32 ET | 12469 | 24.275 |
12:34 ET | 420 | 24.275 |
12:36 ET | 1843 | 24.29 |
12:38 ET | 4434 | 24.255 |
12:39 ET | 4170 | 24.23 |
12:41 ET | 3074 | 24.24 |
12:43 ET | 6354 | 24.25 |
12:45 ET | 3196 | 24.29 |
12:48 ET | 3664 | 24.315 |
12:50 ET | 2200 | 24.295 |
12:52 ET | 2194 | 24.28 |
12:54 ET | 800 | 24.29 |
12:56 ET | 1073 | 24.28 |
12:57 ET | 2108 | 24.25 |
12:59 ET | 1300 | 24.27 |
01:01 ET | 4476 | 24.26 |
01:03 ET | 3427 | 24.23 |
01:06 ET | 1150 | 24.25 |
01:08 ET | 1973 | 24.24 |
01:10 ET | 800 | 24.245 |
01:12 ET | 3300 | 24.23 |
01:14 ET | 6007 | 24.27 |
01:15 ET | 2012 | 24.295 |
01:17 ET | 2360 | 24.28 |
01:19 ET | 3052 | 24.28 |
01:21 ET | 1000 | 24.29 |
01:24 ET | 4188 | 24.335 |
01:28 ET | 2300 | 24.37 |
01:30 ET | 580 | 24.35 |
01:32 ET | 550 | 24.34 |
01:33 ET | 2122 | 24.39 |
01:35 ET | 2330 | 24.43 |
01:37 ET | 766 | 24.42 |
01:39 ET | 780 | 24.41 |
01:42 ET | 2397 | 24.44 |
01:44 ET | 1068 | 24.44 |
01:46 ET | 1376 | 24.47 |
01:48 ET | 800 | 24.5 |
01:50 ET | 2000 | 24.54 |
01:51 ET | 1200 | 24.53 |
01:53 ET | 1475 | 24.54 |
01:57 ET | 2460 | 24.51 |
02:00 ET | 1100 | 24.49 |
02:02 ET | 450 | 24.47 |
02:04 ET | 1040 | 24.48 |
02:06 ET | 10746 | 24.41 |
02:08 ET | 5660 | 24.46 |
02:09 ET | 14613 | 24.505 |
02:11 ET | 1250 | 24.48 |
02:13 ET | 1400 | 24.49 |
02:15 ET | 650 | 24.495 |
02:18 ET | 925 | 24.49 |
02:20 ET | 2750 | 24.52 |
02:22 ET | 2293 | 24.51 |
02:24 ET | 2025 | 24.52 |
02:26 ET | 11953 | 24.565 |
02:27 ET | 900 | 24.525 |
02:29 ET | 950 | 24.515 |
02:31 ET | 8140 | 24.505 |
02:33 ET | 34085 | 24.53 |
02:36 ET | 900 | 24.51 |
02:38 ET | 1300 | 24.54 |
02:40 ET | 2973 | 24.45 |
02:42 ET | 400 | 24.45 |
02:44 ET | 1300 | 24.44 |
02:45 ET | 900 | 24.39 |
02:47 ET | 726 | 24.4 |
02:49 ET | 4634 | 24.4 |
02:51 ET | 550 | 24.38 |
02:54 ET | 1300 | 24.34 |
02:56 ET | 2230 | 24.355 |
02:58 ET | 3600 | 24.33 |
03:00 ET | 3064 | 24.37 |
03:02 ET | 600 | 24.38 |
03:03 ET | 2327 | 24.365 |
03:05 ET | 1600 | 24.37 |
03:07 ET | 3361 | 24.35 |
03:09 ET | 2350 | 24.33 |
03:12 ET | 1615 | 24.31 |
03:14 ET | 941 | 24.28 |
03:16 ET | 6785 | 24.3557 |
03:18 ET | 1867 | 24.35 |
03:20 ET | 1835 | 24.31 |
03:21 ET | 1214 | 24.29 |
03:23 ET | 900 | 24.29 |
03:25 ET | 3099 | 24.23 |
03:27 ET | 3307 | 24.26 |
03:30 ET | 15895 | 24.25 |
03:32 ET | 6341 | 24.24 |
03:34 ET | 3950 | 24.225 |
03:36 ET | 1212 | 24.19 |
03:38 ET | 8665 | 24.15 |
03:39 ET | 9342 | 24.23 |
03:41 ET | 9597 | 24.2 |
03:43 ET | 3814 | 24.19 |
03:45 ET | 5461 | 24.19 |
03:48 ET | 4368 | 24.2 |
03:50 ET | 9433 | 24.17 |
03:52 ET | 14797 | 24.11 |
03:54 ET | 14285 | 24.13 |
03:56 ET | 15549 | 24.095 |
03:57 ET | 19401 | 24.1 |
03:59 ET | 40252 | 24.11 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 3.6B | -4.5x | --- |
Axsome Therapeutics Inc | 3.4B | -13.7x | --- |
Ultragenyx Pharmaceutical Inc | 3.6B | -5.2x | --- |
MorphoSys AG | 2.7B | -12.1x | --- |
Amicus Therapeutics Inc | 3.2B | -21.0x | --- |
Arrowhead Pharmaceuticals Inc | 3.0B | -8.6x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
---|---|
Revenue (TTM) | $305.2M |
Shares Outstanding | 148.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $-5.35 |
Book Value | $-2.24 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | 11.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -232.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.